Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

NSE/SENORES stock hub

NSE/SENORES has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/SENORESis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

44.5B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/SENORES

In the news

Latest news · NSE/SENORES

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E33.5

P25 24.9P50 32.4P75 45.7

Trailing P/E43

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC11.6

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/SENORES market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

154

Groups with data

Currency

INR

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	194
Employees Change	81%
Employees Change Percent	71.68
Enterprise value	INR 45.1B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	INE0RB801010
Last refreshed	2026-05-10
Market cap	INR 44.5B
Price	INR 969
Price currency	INR
Rev Per Employee	28,528,865.98x
Sector	Healthcare
Sic	2834
Symbol	nse/SENORES
Website	https://senorespharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.28%
EV Earnings	44.35x
EV/EBIT	34.67x
EV/EBITDA	29.72x
EV/Sales	8.14x
Forward P/E	33.49x
P/B ratio	5.33x
P/E ratio	43.05x
P/S ratio	8.03x
PEG ratio	0.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.48%
EBITDA Margin	27.13%
Gross margin	54.9%
Gross Profit	INR 3B
Gross Profit Growth	41.24%
Gross Profit Growth Q	57%
Net Income	INR 1B
Net Income Growth	79.28%
Net Income Growth Q	84.28%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	23.92%
Profit Margin	18.36%
Profit Per Employee	INR 5.2M
Profitable Years	1
ROIC	11.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	95.81%
EPS Growth	40.32
EPS Growth Q	44.64
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	43.2x
Revenue Growth Q	60.03x
Revenue Growth Quarters	2x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 2B
Debt	INR 2.4B
Debt EBITDA	INR 1.59
Debt Equity	INR 0.29
Equity	INR 8.3B
Interest Coverage	6.28
Net Cash	INR -385.3M
Net Cash By Market Cap	INR -0.87
Net Debt EBITDA	INR 0.26
Net Debt Equity	INR 0.05
Tangible Book Value	INR 5.2B
Tangible Book Value Per Share	INR 105

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-27.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	95.72%
200-day SMA	767.7
50-day SMA	812.8
50-day SMA vs 200-day SMA	50over200
All Time High	976
All Time High Change	-0.72%
All Time High Date	2026-05-08
All Time Low	435.3
All Time Low Change	122.63%
All Time Low Date	2025-01-13
ATR	34.68
Beta1y	0.27
Beta2y	0.43
Ch YTD	17.86
High	976
High52	976
High52 Date	2026-05-08
High52ch	-0.04%
Low	929.9
Low52	475
Low52 Date	2025-05-09
Low52ch	104%
Ma50ch	19.22%
Price vs 200-day SMA	26.22%
RSI	69.73
RSI Monthly	77.19
RSI Weekly	69.45
Sharpe ratio	1.74x
Sortino ratio	3.19
Total Return	-27.75%
Tr YTD	17.86
Tr1m	25.47%
Tr1w	8.36%
Tr3m	17.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 1.3B
Operating Income Growth	67.97
Operating Income Growth Q	114.8
Operating margin	23.48

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,451,748%
Shares Insiders	36.28%
Shares Institutions	11.75%
Shares Out	46,053,588
Shares Qo Q	-12.28%
Shares Yo Y	27.75%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	313,410.05x
Bv Per Share	164.4
Ch1m	25.47
Ch1w	8.36
Ch1y	95.72
Ch3m	17.41
Ch6m	17.75
Change	3.99%
Change From Open	3.19
Close	931.8
Days Gap	0.77
Depreciation Amortization	202,050,000
Dollar Volume	352,380,726
Earnings Date	2026-05-14
EBIT	INR 1.3B
EBITDA	INR 1.5B
EPS	INR 22.43
F Score	1
Fiscal Year End	March
Founded	2,017
Graham Number	288.0581
Graham Upside	-70.27
Income Tax	INR 295.5M
Is Primary Listing	1
Last Earnings Date	2026-01-20
Last Report Date	2025-12-31
Ma150	795.1
Ma150ch	21.86%
Ma20	891.7
Ma20ch	8.67%
Next Earnings Date	2026-05-14
Open	939
Position In Range	84.82
Price Date	2026-05-08
Price EBITDA	INR 29.61
Ptbv Ratio	8.57
Relative Volume	1.19x
Revenue	5,534,600,000x
Tax By Revenue	5.34x
Tax Rate	22.32%
Tr6m	17.75%
Volume	363,654

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/SENORES pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/SENORES stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/SENORES?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.8%

Share of float held by funds and institutions

Insider ownership

+36.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+27.7%

Negative means the company is buying back shares.

Technical

NSE/SENORES momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

69.7

Neutral momentum band

Price vs 200-day MA

+26.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.74

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/SENORES

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/SENORES stock rating?

nse/SENORES is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/SENORES analysis?

The full report lives at /stocks/nse/SENORES/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/SENORES?

The latest report frames nse/SENORES around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/SENORES page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.